Bronchoplastic lobectomy in non-small cell lung cancer: review of 218 patients
Lists
Only you see this
Abstract
Objective To investigate the indications, postoperative complications and predicting factors after sleeve lobectomy for NSCLC. Methods 218 patients with NSCLC underwent sleeve lobectomy. Results The mortality was 3.2% and morbidity 20.2%. The overall survival rate at 1, 3 and 5 years was 76%, 55% and 42, respectively. Multivariate analysis indicated that N stage (P=0.000) and postoperative adjuvant chemotherapy (P=0.021) were significant factors affecting survival. Conclusion For patients with NSCLC, bronchoplastic lobectomy are an adequate cancer operation. Preoperative and postoperative adjuvant chemo- therapy would play an important role in prolenging survival, particularly in patients with positive N1 or N2 lymph nodes. Key words: Carcinoma, non-small-cell lung; Pneumonectomy; Postoperative complications; Prognosis
BibTeX
@inproceedings{zhu2008bronchoplastic,
author = {Yuming Zhu and Yi Zhang and Gening Jiang},
title = {{Bronchoplastic lobectomy in non-small cell lung cancer: review of 218 patients}},
booktitle = {Chinese},
year = {2008},
doi = {10.3760/cma.j.issn.1001-4497.2008.04.006},
}Loading related content...